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ABSTRACT 
 
EFFECTS OF KNOWLEDGE AND ANXIETY ON WILLINGNESS TO SCREEN 
FOR ALZHEIMER’S DISEASE 
FEBRUARY 2012 
TESSA S. LUNDQUIST, B.A., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Rebecca E. Ready 
 While the prevalence rates of Alzheimer’s disease (AD) are increasing, the 
screening rates for the disease are low. A major barrier to AD screening is older persons’ 
lack of knowledge about the disease (Ayalon & Arean, 2004). Older adults have anxiety 
about AD (Corner & Bond, 2004; Devlin et al., 2007), but less is known about how that 
anxiety may affect their screening behavior. The current study  measured AD Knowledge 
and AD Anxiety and determined how these factors were related to Willingness to Screen 
for AD in a sample of midlife and older adults (N = 96, mean age = 62.45, range 55 to 
86). It was expected that greater AD Knowledge would be associated with more 
Willingness to Screen and that higher AD Anxiety would be associated with less 
Willingness.  Further, it was hypothesized that AD Anxiety would moderate the 
relationship between AD Knowledge and Willingness. AD Knowledge and Trait Anxiety 
were not significant predictors of Willingness to Screen, while AD Anxiety was 
positively associated with Willingness. AD Anxiety moderated the relationship between 
AD Knowledge and Willingness. When individuals had lower AD Anxiety, their 
Willingness increased as their AD Knowledge increased. In contrast, for participants with 
relatively more AD Anxiety, their Willingness decreased as their AD Knowledge 
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increased. Understanding how knowledge about AD affects older adult screening 
preferences differently based on the amount of anxiety they have about AD will facilitate 
development of the most effective interventions to increase awareness about AD and 
promote screening. 
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CHAPTER I 
THE CURRENT STATE OF ALZHEIMER’S DISEASE AND SCREENING 
STANDARDS 
The United States population is aging at an unprecedented rate and chronic 
diseases related to aging are affecting more individuals and families. Alzheimer’s disease 
(AD) is one of the most prevalent diseases of aging; an estimated 4.5 million Americans 
are currently diagnosed with AD and an estimated 7.7 million are expected to have the 
condition by 2030 (Burgener & Berger, 2008). AD causes suffering for families as well as 
societal burden, with an annual estimated cost close to 100 billion dollars (Boustani et al., 
2005; Ernst, Hay, Fenn, Tinklenberg, & Yesavage, 1997). AD is generally met with 
misunderstanding, fear, and stigma (Devlin, MacAskill, & Stead, 2007). 
 Despite five FDA approved drugs for AD that can temporarily slow the 
progression of symptoms (Alzheimer’s Association, 2008), and the fact that active 
management of the disease can improve quality of life for patients and their caregivers 
(Connell, Roberts, McLaughlin, & Carpenter, 2009), older adults are reluctant to seek 
screening for AD. One major reason that older adults are not screened is a lack of 
knowledge about AD and its symptoms (Ayalon & Arean, 2004). Older adults do not 
know when or why it is necessary to seek memory evaluations (eg., Devlin et al., 2007; 
Galvin, Fu, Nguyan, Glasheen, & Scharff, 2008;  Knopman, Donohue, & Gutterman, 
2000; VonDras, 2009; Hughes, Tyler, Danner, & Carter, 2009; Werner, 2003b). Thus, 
many researchers have suggested implementing programs to raise awareness about AD 
and encourage screening by increasing knowledge about the disease and its available 
treatments.  
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 Another barrier to screening may be anxiety about AD, but less is known about 
the effect of anxiety on screening behavior. Whereas dementia clearly evokes anxiety and 
feelings of dread in older adults (Corner & Bond, 2004; Devlin et al., 2007), the extent to 
which those feelings of anxiety may prevent older adults from screening, especially if 
they are experiencing memory problems, is not known.  The current study will address 
this gap in the literature by measuring older adults' anxiety about AD and how it is related 
to willingness to screen. In addition, older adults’ knowledge about AD and how it is 
related to willingness to screen will be measured. Further, the current study will examine 
how anxiety and knowledge may work together in predicting older individuals’ 
willingness to screen. It is important to investigate not only how knowledge impacts 
willingness to screen, but also how anxiety about AD may affect older persons' screening 
behaviors. By understanding the impact of knowledge and anxiety on individuals' 
willingness to screen for the disease, effective interventions aimed at encouraging 
screening can be implemented.  
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CHAPTER II 
KNOWLEDGE ABOUT ALZHEIMER’S DISEASE 
 
A. Deficits in Knowledge about Alzheimer’s Disease 
 As stated above, knowledge about AD affects older individuals’ willingness to 
screen for the disease.  In a study exploring how certain psychosocial factors are related 
to willingness to screen for AD, Galvin et al. (2007) found that knowledge of AD and its 
consequences was a significant predictor of willingness to screen. Participants who had 
knowledge about dementia and had some idea of the negative impact AD could have on 
them and their family members were most likely to express intention to screen for AD. 
Similarly, in a study measuring the relationship between knowledge about AD and 
willingness to seek help for the disease, Werner (2003b) found that older individuals 
having a higher amount of knowledge about AD symptoms were significantly more likely 
to express intention to seek professional help for memory problems.  However, older 
adults often show wide-ranging deficits in knowledge about AD, including poor 
knowledge about symptoms, available treatments, course and severity of the disease, and 
etiology of AD (Ayalon & Arean, 2004).  Older individuals cite deficits in knowledge as 
obstacles to seeking assessment for AD. For example, many persons think that all 
memory problems are parts of normal aging, that a diagnosis of AD is unnecessary, and 
that there is no treatment for AD (Connell et al., 2009). In a study of in-depth interviews 
with older persons, Werner (2004) found that older individuals generally thought that 
memory problems were an inevitable part of aging. Participants who had knowledge 
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deficits about normal aging versus AD symptoms expressed more reluctance about 
seeking AD screening.    
 
B. Identifying Memory Changes 
 Often, older persons are not able to distinguish memory changes due to normal aging 
from those that are early signs of AD (Werner, 2004; Knopman et al., 2000).  Memory 
normally declines with age, with younger persons performing better on memory tasks and 
having fewer memory impairments than older persons (Cutler & Hodgson, 1996).  Devlin 
et al. (2007) conducted qualitative interviews with persons over the age of 50, who will 
be at a higher risk for AD as they age. They wanted to explore the views that adults had 
about AD to get an idea about how mass media campaigns designed to raise awareness 
about dementia could be most effective in the future.  Focus groups were conducted with 
older persons to explore issues such as knowledge and awareness about AD, perceptions 
and beliefs about treatment and support for AD, and issues related to approaching a 
primary care doctor with concerns about AD (Devlin et al., 2007). Results indicated that 
even though participants had a general awareness about dementia, they had significant 
misperceptions about AD.  Participants were uncertain about the onset of the disease and 
what memory changes were normal for aging, including what memory problems would 
be considered severe enough to be symptomatic of AD (Devlin et al., 2007). One 
participant said “I forget quite a lot, I don't think it's got anything to do with dementia” 
(Devlin et al., 2007, p. 51). The respondents' uncertainty about the onset of AD may have 
led to some complacency about memory problems.  Several participants reported that 
when they experienced memory changes, they would attribute them to normal aging, until 
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the symptoms became so bad that they could not avoid them any longer (Devlin et al., 
2007).   
 A common memory occurrence that would be considered normal for aging would 
be forgetting names or appointments, but then being able to remember them later.  This 
type of memory change is called a retrieval deficit, which means that information that is 
stored in memory is not easily accessible (Broder, Herwig, Teipal, & Fast, 2008).  Most 
older persons would be able to retrieve the memory eventually, while someone with AD 
would not.  Memory impairment in AD is partly attributed to difficulty with storage and 
retrieval of long-term memories, as well as deficits in learning new material (Chang et 
al., 2010).  Though some types of memory problems are considered normal for aging and 
are common in daily life (i.e., retrieval deficits), they are different from memory loss (i.e., 
amnesia) that is symptomatic of AD.  Cognitive impairment, a symptom of AD, occurs 
when deficits contribute to functional impairment that is sufficient to interfere with 
everyday activities (APA, 2000). An example of a functional change associated with 
aging would be an individual occasionally needing help adjusting the television or 
operating appliances, whereas a sign of AD would be an individual having difficulty 
completing daily tasks, such as having difficulty driving to familiar places, or being 
unable to manage work duties (Alzheimer's Association, 2008).  In AD, functional 
impairment is often accompanied by changes in mood, personality, and behavior (Rabin 
et al., 2008).  
C. Knowledge about Treatment Options 
 In addition to not being able to identify symptoms of AD, many older individuals 
also do not have knowledge about available treatments for AD. To  measure what older 
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individuals thought were barriers and benefits to seeking a diagnosis of AD, Connell et al. 
(2009) administered questionnaires to a sample of adults.  All respondents reported 
having a family member currently diagnosed with AD. Connell et al. (2009) found that 
many participants endorsed screening barriers that were related to treatment, such as 
items stating that “so little can be done for people with AD” and “there is no effective 
treatment for AD” (Connell et al., 2009, p. 1565). 
   Werner (2003a) examined barriers associated with older adults’ intention to seek 
memory screening when those older adults felt that they were experiencing memory 
problems themselves.  Barriers included a lack of knowledge about the utility of having a 
memory evaluation and a lack of knowledge about treatments for the disease (Werner, 
2003a).  As discussed previously, Devlin et al. (2007) found that the majority of older 
individuals in their sample were unsure of how to distinguish normal memory changes 
related to aging from memory symptoms of AD. They also found that participants were 
not aware of drug treatments and did not believe that there was any clinical treatment 
available for AD, which contributed to participants' perceptions that there was little 
benefit to seeking diagnosis (Devlin et al., 2007). When exploring older adults’ intention 
to seek memory screening in the presence of memory problems through in-depth 
interviews, Werner (2004) found that individuals who believed in the efficacy of AD 
treatment expressed a greater intention to seek help for memory problems. 
 
D. Knowledge about Risks and Consequences 
When older adults lack knowledge about AD it can affect how susceptible they 
think they are to developing the disease, which in turn can affect their willingness to 
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screen for it.  Galvin et al. (2007) measured intention to screen for AD in a sample of 
older adults and found that in addition to having knowledge about the disease in general, 
older adults who were able to recognize the consequences of having AD and its negative 
effect on them and their family were most likely to express intention to screen (Galvin et 
al., 2007). These individuals were able to see a tangible benefit to seeking a diagnosis for 
AD through their knowledge about the disease, which outweighed what they thought 
were barriers to screening.  Perceived susceptibility is greatly affected by knowledge of 
the disease in general, as well as the specific knowledge that AD is an illness and not a 
part of normal aging (Hughes et al., 2009).  Galvin et al. (2007) suggest that more 
knowledge about AD leads to more perceived susceptibility and higher perceived benefit 
to screening, noting that increasing knowledge in older adults would have a positive 
impact on screening behavior.  
E. Ethnic Differences in Knowledge 
Differences in ethnicity serve as an example of the importance of knowledge in 
individuals’ willingness to screen for AD. Ayalon and Arean (2004) found that there were 
significant differences in amount of knowledge about AD across four different ethnic 
groups of older adults. Even though AD is more prevalent in certain ethnic groups, with 
rates being highest in African Americans, these groups are likely to receive diagnoses of 
AD at later stages in the disease, which in turn limits their access to early interventions 
and available treatments (Ayalon & Arean, 2004; Hughes et al., 2009). Ayalon and Arean 
(2004) tested Anglo-Americans, Latino, Asian, and African American older adults and 
found that across all groups, the majority of older persons had significant misperceptions 
about AD in general, including prevalence, etiology, diagnosis, financial options for 
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treatment, and course of the disease. African Americans, Latino, and Asians had 
significantly less knowledge about AD than Anglo Americans.  Additionally, some 
ethnicities held inaccurate beliefs about the etiology of AD. Ayalon and Arean (2004) 
found that Asian American and Latino older individuals thought of AD as a contagious 
disease and tended to think of memory problems as being caused by the fault of the 
individual.  Certain ethnic groups’ lack of knowledge about AD could account for their 
low detection rates (Ayalon & Arean, 2004).  The authors suggest that interventions and 
campaigns to increase awareness in minority populations should try to increase 
knowledge about AD and inform, for example, that it is not contagious and is not a 
normal part of aging (Ayalon & Arean, 2004).  
 Hughes et al. (2009) found a lack of knowledge about AD in ethnic minority 
caregivers of individuals diagnosed with AD. They retrospectively studied experiences of 
African Americans and what led them to seek an AD evaluation for their family member 
by conducting interviews with caregivers of persons with AD, which included mostly 
adult children of AD patients, and a small number of spouses. When asked “Prior to your 
family member being diagnosed, how much did you know about Alzheimer's disease?” 
most caregivers reported having little knowledge of the disease (Hughes et al., 2009). 
One participant said “I first learned about it when I discovered that my mother was 
diagnosed with the illness. I really did not know about it, I mean I had heard the word, 
the term, but I never did understand it that well until it happened to my mom” (Hughes et 
al., 2009, p. 103). Multiple caregivers noted that they were aware of AD as a disease prior 
to the diagnosis of their family member, but lacked sufficient knowledge of symptoms, 
progression of the disease, and behavioral changes associated with AD (Hughes et al., 
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2009). In fact, almost half of the respondents initially attributed the memory impairment, 
loss of intellectual ability, and personality change seen in their family member to normal 
aging. Research has shown that African Americans generally have less knowledge about 
AD (Ayalon & Arean, 2004) which contributes to the fragmented process and delay to 
diagnosis that they often experience (Hughes et al., 2009).  
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CHAPTER III 
ANXIETY ABOUT ALZHEIMER’S DISEASE 
A. Research Exploring Anxiety about AD 
  As reviewed previously, the amount of knowledge a person has about the 
symptoms of AD, the impact of the disease, available treatment options, and the 
usefulness of screening are related to individuals' willingness to screen for AD, but the 
feelings an individual has about the disease may play a crucial role as well (Corner & 
Bond, 2004). Knowledge about AD may not be enough to explain screening behavior.  
Minimal research has examined how individuals decide whether and when to seek 
memory evaluation once they have identified memory impairment in themselves (Connell 
et al., 2009). It is clear that aging may be anxiety provoking for some individuals, 
demonstrated, for example, by a reluctance to interact with older persons or refusal to 
acknowledge one’s age (Lasher & Faulkender, 1993).  AD also evokes anxiety and 
feelings of dread in older adults and is associated with fears of losing control, identity, 
and dignity (Devlin et al., 2007). When measuring general health anxiety of community-
dwelling older adults, Wisocki et al. (1988) found that failing memory was one of their 
primary health related worries (as cited in Borgault–Fagnoult & Hadjistavropoulos, 
2008). 
 To begin to look at feelings about AD, Corner and Bond (2004) conducted 
qualitative interviews with older adults. The sample included adults over the age of 60 
taken from a larger study examining quality of life from the perspective of individuals 
diagnosed with dementia and their caregivers. Overall, participants had considerable fear 
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and anxiety about developing AD.  While there were individuals who could identify 
memory problems as possible AD symptoms, some of them reported that anxiety would 
inhibit them from seeking a memory evaluation (Corner & Bond, 2004).  One participant 
was quoted as saying “As soon as you get forgetful you think: 'is it going to happen to 
me?' It’s frightening really” (Corner & Bond, 2004, p. 147).  Another participant said “the 
mere thought of dementia terrifies me...more than any other thing [disease] to die from...” 
(Corner & Bond, 2004, p. 148).  In fact, the researchers discussed difficulties they had 
recruiting for the study, when ten of the twenty-five people initially approached declined 
to participate, citing that they would be uncomfortable discussing the topic of AD and 
that it would raise painful issues for them. This refusal rate is higher than common for 
similar studies, which may itself serve as an example of the fear and anxiety older 
individuals have about AD (Corner & Bond, 2004).  
B. Stigma and Anxiety 
In a study testing the implementation of a screening program for AD, Boustani et 
al. (2005) sampled patients, ages 65 and older, from seven primary care clinics and 
offered them a brief six item screening questionnaire of memory functioning. The 
researchers then offered a full diagnostic evaluation to patients who screened positive for 
memory impairment. The offer of further evaluation was made with several incentives; 
the patient's physician recommended it, the study staff talked about the importance of the 
assessment, and it was offered free of charge, since it was being performed in the primary 
care clinic. While only six percent of patients refused the brief six-item screening 
questionnaire, half of the patients with positive screening results refused further 
diagnostic assessment. This high refusal rate is similar to another study by the same 
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authors examining attitudes in residents of continuous care communities towards AD 
screening. In this study, 51% of residents would not agree to routine memory screening 
(Boustani et al., 2005). The authors note that the high refusal rate in both studies may be 
related to a fear that a diagnosis of AD would be a source of stigma and could lead to 
emotional harm (Boustani et al., 2005). In fact, Burgener and Berger (2008) write about a 
woman who removed her husband from treatment centers for AD and stopped 
medications for AD because the “diagnosis of Alzheimer’s was just too stigmatizing for 
her and her husband to accept” (Burgener & Berger, 2008, p.36). Stigmatizing attitudes, 
which are associated with many chronic diseases, especially those involving mental 
health, can make persons more anxious about developing the disease themselves (Jorm, 
2000). When designing a campaign to increase awareness about AD, Devlin et al. (2007) 
found that the public generally held negative views towards individuals with dementia, 
because they tended to think about persons with AD in the later and more severe stages of 
the disease. 
C. Media Influences 
Individuals may form negative attitudes about aging and AD through general 
public opinion or media images. Many individuals rely on media as their main source of 
information about chronic diseases and mental disorders.  A German study found that the 
negative depictions of mental diseases in the media led to an increase in negative 
attitudes about those disorders (Jorm, 2000). In the case of AD, it is usually the most 
despairing features of the disease that are depicted in the media, contributing to 
stereotypes about AD and adding to the fear of the disease (Corner & Bond, 2004).  
Public figures diagnosed with AD, such as former president Ronald Reagan, are 
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presented as experiencing the most debilitating and dreadful aspects of AD. When 
conducting in-depth interviews with older individuals to explore their fears about AD, 
Corner and Bond (2004) found that many participants were influenced by these negative 
media portrayals when thinking about AD.  Participants referenced the media images, 
focusing on their perceived loss of independence, control, and dignity when expressing 
their fear about developing AD. 
D. How Anxiety May Effect Screening for AD 
1. Avoiding Exposure to AD 
While it is clear that some older individuals have significant anxiety about 
developing AD (Corner & Bond, 2004; Devlin et al., 2007; Boustani et al., 2005; 
Burgener & Berger, 2005), less research has been done on how this anxiety about AD 
may affect their willingness to screen for the disease.  For some individuals, anxiety 
about a disease will be manifested by their avoidance of that disease. As discussed 
previously, Corner and Bond (2004) conducted interviews with older adults and found 
that they had considerable fear and anxiety about AD. They found that many participants 
actively tried to distance themselves from the possibility of having AD. Particularly, 
participants who had a family history of the disease purposely did not tell their primary 
care doctors about memory loss they were experiencing, reporting that they did not want 
their doctor to realize the family connection and evaluate their memory further (Corner & 
Bond, 2004). Participants wanted to put off the inevitable as long as possible, and were 
frightened of hearing from their doctors that they might have AD.  Corner and Bond 
(2004) also found that negative feelings about AD came from the experiences of visiting 
friends and family members with the disease who were living in a long term care setting. 
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These individuals formed negative views of AD from these visits, which eventually lead 
them to no longer visit those friends or relatives. Some participants reported consciously 
trying not to think about AD, with one participant saying “No, I daren’t let myself think 
about it. I just push it to the back of my mind, and try not to think of it” (Corner & Bond, 
2004, p. 148). Individuals who avoid receiving or thinking about threatening disease 
information report lower levels of anxiety about that disease (VonDras, 2009).  Avoiding 
someone with the disease or avoiding thinking about the disease lowers its perceived 
threat, and when illnesses are perceived as less life threatening, there may be greater 
delay in seeking care (VonDras, 2009).  In the case of AD, after conducting small focus 
groups and interviews with adults over the age of 50, Devlin et al. (2007) found that these 
individuals’ anxieties about AD contributed to a feeling of avoidance of the disease, 
demonstrated by the participants reporting that they would put off memory evaluation if 
they were experiencing memory changes. Participants cited feeling frightened of what 
would happen to them once they received a diagnosis of AD, further reporting feeling 
shock and dismay at the thought of receiving an AD diagnosis (Devlin et al., 2007). 
2. Anxiety Leading to Hyper-vigilance 
As discussed above, anxiety may lead to fear and avoidance of AD, which may 
lead to less willingness to screen and undergo a memory evaluation. Alternatively, 
anxiety may lead to hyper-vigilant symptom checking, to the point where an individual 
“symptom-seeks” for memory impairment in themselves (Hodgson & Cutler, 2003; 
Cutler & Hodgson, 1996). Individuals who are overly anxious about the possibility of 
developing AD may represent a group of older persons who are the “worried well” 
(Hodgson & Cutler, 2003). This “anticipatory dementia” involves searching for memory 
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changes in oneself and identifying them as warning signals of AD. Werner (2003a) found 
that older adults who worried more about developing AD gave themselves worse memory 
evaluations than older adults less worried about AD.  Suhr and Kinkela (2007) studied the 
process by which believing in negative aging stereotypes contributes to heightened health 
anxiety about aging. Memory loss is a widespread stereotype associated with aging.  
Older individuals internalize the stereotype and thus become more sensitive to memory 
changes in themselves, making them more likely to over-estimate the severity of memory 
changes that they experience. While the concept of anticipatory dementia is linked to 
more concern about the disease and increased symptom seeking for signs of AD, research 
has not examined whether that concern leads to more or less willingness to screen, or 
other psychological consequences, such as depression in later life (Cutler & Hodgson, 
1996). Instead of avoiding screening, these individuals may seek evaluation and 
treatment when they have no cause to, which increases risks of misdiagnosis and 
initiation of unnecessary medications (Suhr & Kinkela, 2007). 
3. An Ideal Level of Anxiety 
When designing an effective campaign to raise awareness about AD, Devlin et al. 
(2007) found that older persons’ anxiety about the disease did contribute to a feeling of 
avoidance of the disease and the desire to put off receiving a diagnosis of AD. They 
speculate that providing more information about treatment options and more information 
about effective social supports, such as education and counseling, could encourage people 
to seek diagnosis earlier (Devlin et al., 2007).  There is a large body of research on health 
campaigns designed to raise awareness for various diseases.  The idea of “fear appeals” is 
that  fear and anxiety about a disease can be utilized by the campaign to motivate persons 
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to engage in disease prevention behavior (Tanner, Hunt, & Eppright, 1991).  In the case 
of AD, fear appeals may motivate older individuals to approach their doctors and to get 
screened if they are experiencing memory problems.  If older individuals do have anxiety 
about AD that is affecting their health seeking behavior, anxiety will be important to 
consider when awareness campaigns are implemented in the future (Devlin et al., 2007).  
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CHAPTER IV 
 KNOWLEDGE, ANXIETY, AND WILLINGNESS TO SCREEN FOR AD 
A. Current Study 
 While it is important to understand how knowledge and anxiety may separately 
affect older individuals' willingness to screen for AD, it is also important to consider how 
knowledge and anxiety may interact in predicting willingness to screen. There are lags 
between the first signs of AD and when individuals recognize those signs as problems, 
and also between the first recognition of AD symptoms and professional evaluation 
(Knopman et al., 2000).  Studies have found that only 26% of older persons who worried 
about their memory functioning consulted their physicians about memory problems 
(Werner, 2003). These studies indicate that even if an individual is able to identify 
memory impairment (e.g. they have adequate knowledge about AD), something is 
inhibiting them from getting evaluated. Anxiety may be one factor that keeps older adults 
from seeking an evaluation even when they have recognized the symptoms (Corner & 
Bond, 2004; Von Dras, 2009). 
 The current study measured knowledge about AD and determined how it was 
related to willingness to screen for AD in a sample of older adults, aged 55 and older. 
Anxiety about AD and how anxiety was related to willingness to screen for AD was also 
determined.  Additionally, the interaction between knowledge and anxiety was measured 
to examine how anxiety may have moderated the relationship between knowledge and 
willingness to screen.   
B. Hypotheses 
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Based on previous research (Ayalon & Arean, 2004; Werner, 2003; Galvin et al., 
2008; Connell et al., 2009), it was hypothesized that less knowledge about AD, as 
measured by the Alzheimer’s Disease Knowledge Scale, would be related to less 
willingness to screen for AD. The relationship between anxiety and willingness to screen 
was determined as well.  While there are mixed results about anxiety about AD and 
health-seeking behavior, there are particularly compelling studies that find that anxiety 
about AD is related to avoidance of the disease (Corner & Bond, 2004; VonDras, 2009; 
Devlin et al., 2008).  Since anxiety about a disease may lead to avoidance of that disease, 
it was hypothesized that a higher amount of anxiety would be related to less willingness 
to screen for AD.  Additionally, as an exploratory hypothesis, it was expected that anxiety 
would moderate the relationship between knowledge and willingness to screen. As 
discussed, there are delays between first recognition of symptoms of AD and eventual 
memory evaluation (Knopman et al., 2003; Werner, 2003). Even though individuals may 
have knowledge with which they recognize disease symptoms, they delay in having them 
evaluated. Anxiety about AD may be one factor that can explain why adults do not seek 
AD screening.  Even if someone has enough knowledge about AD to recognize the 
symptoms and consequences of the disease, if they have a high amount of anxiety, it may 
weaken the positive association between knowledge and willingness to screen. While 
higher knowledge about AD is related to more willingness to screen (Galvin et al., 2007; 
Werner, 2003b), anxiety about AD may explain why screening rates continue to be low.  
C. Significance and Impact 
 As prevalence rates of AD rise, early detection of AD is becoming more important 
to introduce treatment in the beginning stages of the disease. It also affords family 
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members an opportunity to understand their loved one’s behavior and make informed 
decisions about future care (Connell et al., 2009). When individuals receive a diagnosis 
of AD in the early stages, they can opt to begin treatment programs or even participate in 
clinical trials where they may be administered experimental treatments not yet available 
to the public that can be effective in slowing the progression of AD. Interventions such as 
educational materials and workshops about AD increase a sense of control and decrease 
distress in caregivers, while drug treatments for AD have been shown to slow the 
progression of cognitive decline (Ayalon & Arean, 2004; Connell et al., 2009).  
 The benefits of early detection and diagnosis of AD have driven an interest in 
screening programs for older persons (Ashford et al., 2007; Werner, 2004).  Since it is 
difficult for patients and primary care doctors to recognize AD, especially when the 
symptoms are mild, it is important to have effective routine screening tools that can be 
implemented in primary care settings (Ashford et al., 2007). For older adults who do not 
have adequate knowledge of AD and its symptoms, it is often not until a triggering event 
of memory loss occurs, such as forgetting to turn off the stove, that they will seek a 
memory evaluation (Hughes et al., 2009). Behavior changes and functional impairment 
associated with AD that remain unrecognized can become dangerous, and safety concerns 
can arise. For example, individuals with AD have twice the rate of motor vehicle 
accidents than matched individuals without AD (Knopman et al., 2000).  
 Once knowledge and anxiety about AD are measured and better understood, the 
best interventions to promote screening and early detection of AD can be designed. There 
is extensive knowledge about effective health campaigns which indicate that it is optimal 
to balance “fear-appeals” as motivation while not causing too much heightened anxiety 
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about the disease in question (Devlin et al., 2007; Tanner et al., 1991). The amount of 
anxiety older persons have about AD will affect how they respond to campaigns trying to 
motivate individuals to screen for AD.  By measuring two potential barriers to AD 
screening (e.g. low knowledge and high anxiety about AD), we will begin to discern 
whether one acts as a bigger barrier to AD screening and how they may interact, and 
therefore be able to inform the content of future effective interventions and education 
campaigns about AD.
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CHAPTER V 
METHOD 
A. Participants 
 Participants were 111 community-dwelling, English-speaking healthy older adults 
who were aged 55 years and above. Data from fourteen participants were cut from final 
analyses because the participants did not provide their age and thus may not have fit one 
of the main study criteria of being at least aged 55. One participant's data was excluded 
because she reported having a diagnosis of MCI. The final sample size was 96. Data 
collection began in July, 2010, and continued until May, 2011.  Recruitment involved 
fliers posted throughout the community with information about the study and tear-offs 
containing contact information of the investigator and web address of the website where 
potential participants could complete the survey online. Emails were sent to members of 
an existing database of older adults.  Finally, emails were sent to family members and 
acquaintances, asking them to pass along information about the study to anyone they 
knew that fit study criteria and that might be willing to participate.  As an incentive, 
participants were entered into a raffle with the opportunity to win one of four gift cards to 
a popular book store chain.  
B. Procedure 
 Data were collected mainly through an online survey site. One hundred and seven 
participants completed the survey electronically via the website. Four participants 
completed paper surveys in person after attending a local memory event. 
 The online survey contained an electronic consent form that participants were 
22 
  
required to read and sign before participating. If online participants did not complete the 
consent page, they could not proceed to the questionnaires and were instead directed to a 
web page thanking them for their interest and concluding their participation. If online 
participants did complete the consent page, they were directed page by page to the 
following questionnaires: Brief Screening Question; Demographic Questionnaire; 
Willingness to Screen for Chronic Diseases; AD Knowledge Quiz; AD Anxiety 
Questionnaire; State Trait Anxiety Y2; Ten Item Personality Inventory; Willingness to 
Screen for AD Questionnaire. Participants who completed the paper version of the survey 
were given a packet of survey materials to complete in person.  The first questionnaire in 
the survey contained two screening questions asking participants if they currently had a 
diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or any other type of 
dementia. If participants did have a diagnosis of AD, MCI, or dementia, their data were 
not included in analyses. There was an information page preceding the questionnaires 
with information about what types of questions would be asked and a statement 
informing participants that they could feel free to skip any items that they did not want to 
answer. The AD Knowledge quiz and AD Anxiety questionnaire were counterbalanced 
among surveys, so approximately half of the participants filled out the AD Anxiety 
questionnaire before they completed the AD Knowledge quiz, and approximately half of 
the participants completed the AD Knowledge quiz before filling out the AD Anxiety 
questionnaire. The survey was ordered in this way to detect potential priming effects that 
could occur from answering quiz questions about AD before filling out the AD Anxiety 
questionnaire. After completing the survey, participants were provided a debriefing form, 
as well as an information sheet about AD. All procedures were reviewed and approved by 
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the Institutional Review Board at the University of Massachusetts Amherst.    
 A power analysis of the association between the interaction of AD Knowledge, 
AD Anxiety, and Willingness to Screen for AD was conducted to detect an effect size of 
.10 of the multiple regression R-squared increase for the moderation effect. Power was 
run based on Cohen’s effect sizes with an alpha set at .05. Power analysis revealed a 
necessary sample size of 100 subjects. This sample would allow a detection of a small 
effect size for the interaction of AD Anxiety and AD Knowledge on Willingness to 
Screen for AD with a power of 80 percent. 
C. Measures 
1. Brief Screening Questionnaire 
The screening questionnaire consisted of two questions asking participants if they 
currently had a diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or any 
other type of dementia. The questionnaire contained instructions that if the participant 
answered yes to either question, they should not fill out any more questionnaires and that 
their participation would be considered complete. By including this screening 
questionnaire, any participants who did not fit study criteria were identified and could be 
excluded from data analysis. 
2. Demographic Questionnaire 
The demographic questionnaire assessed participants’ age, gender, race, 
occupation, education, marital status, experience with AD, current and/or past 
psychological and/or neurological diagnoses, and memory concerns. The questionnaire 
also contained questions about the participant's current health seeking behavior, for 
example, whether or not they got regular check-ups with their primary care doctor.  
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3. Willingness to Screen for Chronic Diseases 
Willingness to screen for chronic diseases that are common for aging, including 
AD, was asked at the beginning of the survey, in order to reveal possible differences 
between how willing participants are to screen for AD versus other diseases of aging. 
Another purpose of this questionnaire was to lead participants away from assuming that 
we were mainly interested in willingness to screen for AD. The questionnaire asked 
participants to rate on a scale of one to ten, with one being “not at all willing” and ten 
being “extremely willing,” how willing they would be to screen for nine common chronic 
diseases, such as cancer, heart disease, and AD.  
4. AD Knowledge Quiz 
Knowledge about AD was assessed using the Alzheimer’s Disease Knowledge 
Scale (Carpenter, Balsis, Otilingram, Hanson, & Gatz, 2009). It is a thirty item true/false 
quiz about risk factors, assessment and diagnosis, symptoms, course, life impact, 
caregiving, and treatment and management of AD. The test can be used to assess 
knowledge about AD among laypeople, patients, caregivers, and professionals, with 
higher scores indicating more knowledge about AD. There are no subscales; rather a total 
knowledge score is derived from this measure. In a sample of 40 adults aged 22-87, 
scores on the ADKS ranged from 19 to 30 (M = 24.2, SD = 2.4), there was adequate test-
retest reliability of 0.81, and there was adequate internal consistency reliability 
(Cronbach's alpha = 0.71) (Carpenter et al., 2009).  
5. Anxiety Questionnaires 
Trait anxiety and AD anxiety were measured. To our knowledge, no questionnaire 
currently exists that measures an individual’s amount of anxiety about AD.  By including 
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measures of trait anxiety as well as having a measure of anxiety about AD, we could 
learn if established measures may adequately capture this construct, or if a more specific 
measure was needed.   
6. AD Anxiety 
Items to assess anxiety about AD were constructed for this study.  Questions were 
asked on a 5-point Likert-type scale, with participants being asked to rate the extent to 
which they agree or disagree with each item. In addition to items rated on a scale, there 
were two open ended questions asking participants to describe their feelings of anxiety 
about developing AD in the future. By including two open-ended items, we were able to 
collect potentially interesting descriptive and narrative data on participants’ feelings of 
AD anxiety.  
7. State Trait Anxiety Inventory Form-Y2 (STAI) 
The trait version of the State-Trait Anxiety Inventory Form Y-2 is a widely used 
tool to assess clinical anxiety and consists of twenty statements to evaluate how the 
participant generally feels. Test-retest reliability in a sample of 25 college students after 
104 days was 0.73. The median internal consistency alpha coefficient was 0.90 
(Spielberger, 1983).   
8. Ten-Item Personality Inventory (TIPI) 
The Ten-Item Personality Inventory is a brief measure of the Big-Five personality 
dimensions (Gosling et al., 2003). The Big-Five personality framework is a widely used 
model of personality traits. The TIPI was developed to be a brief screening measure of 
the Big Five. The TIPI was used in the current study in order to measure Neuroticism as 
part of the study’s measure of trait anxiety. The TIPI was significantly correlated with the 
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BFI, ranging from 0.65 to 0.87 across the personality domains of Extraversion, 
Agreeableness, Conscientiousness, Emotional Stability, and Openness to Experience. 
Test-retest reliability of the TIPI in a sample of 180 college students after six weeks was 
0.72 (Gosling et al., 2003).   
9. Willingness to Screen for AD  
Participants’ willingness to screen for AD was asked through a variety of 
questions. Participants were asked to answer how much they agree or disagree with six 
statements on a 5-point Likert-type scale. One item asked participants to rate how willing 
they would be to screen for AD if they felt they were experiencing memory problems.  
The theory of reasoned action (TRA) indicates that intention is an important predictor of 
future behavior (Galvin et al., 2007).  Asking older individuals if they would be willing to 
undergo AD screening in the presence of memory problems can indicate their likelihood 
of future screening behavior. There also was one item asking participants to rate on a 
scale from one to ten how willing they would be to undergo a screening test for AD if 
they felt they were experiencing memory problems.  This latter item was similar to a 
study conducted by Werner (2003a), where willingness to screen was measured by one 
item asking participants to rate how willing they would be to seek a cognitive status 
examination in the next year on a scale of one to ten. By including this item as well as six 
others, we constructed a scale measuring willingness to screen for AD. Additionally, the 
measure included one item asking participants to rate on a scale of one to ten how likely 
they feel it is that they will develop AD at some point in the future.   
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CHAPTER VI 
RESULTS 
A. Preliminary Analyses 
1. Participant Characteristics 
Data from a total of 96 participants were included in analyses, but there were 
some missing data due to participants’ missing items on individual scales. Scale scores 
were included in analyses when 20% or fewer items were missing. If participants had 
more than 20% of items missing on a given scale, their data were excluded from analyses 
using listwise deletion. In the primary analyses, which included regressions to explore the 
relationships among AD Knowledge, AD Anxiety, and Willingness to Screen for AD, 81 
participants’ data were included.  In the regression exploring the relationships among AD 
Knowledge, Trait Anxiety, and Willingness to Screen for AD, 85 participants’ data were 
included in analyses.   
Participants averaged 62.45 years of age with 16 years of education (Table 1). 
The majority of participants reported their race as Caucasian (n = 94), one participant 
reported their race as Hispanic or Latino, and one participant did not provide their race. 
Because of the lack of racial diversity within the sample, no analyses examined 
differences in outcomes between races. There were more female (n = 79) than male (n = 
17) participants in the current study. Gender differences for Trait Anxiety, AD 
Knowledge, Willingness, and AD Anxiety are presented in Table 2. There were no 
significant differences between genders among these variables.  
2. Development of AD Anxiety Score 
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A Principal Components Factor Analysis was conducted on items from the AD 
Anxiety questionnaire. On an exploratory basis, two factors were extracted. The factor 
matrix revealed that six of the fifteen total items loaded highly (>0.50) on one factor.  
Items loading on the first factor were interpretable and had content related to worry about 
AD.  Items on the second factor had low loadings and content did not converge on a 
coherent construct.  As a result, a second Principal Components Factor Analysis was 
conducted from which one factor was extracted, which accounted for 29.82% of the total 
variance. When one factor was extracted, seven items loaded highly (>0.50) on the factor 
(Table 3). This factor was labeled ‘AD Anxiety.' The remaining eight items did not hang 
together and were excluded from further analyses.   
3. Inter-correlations among Anxiety Measures 
Correlations were calculated among the three anxiety measures of AD Anxiety, 
STAI, and Neuroticism. All of these measures were significantly inter-correlated (AD 
Anxiety and Neuroticism, r = 0.29, p < .01; AD Anxiety and STAI, r = 0.33, p < .01; 
STAI and Neuroticism, r = 0.55, p < .01). Since the two measures of trait anxiety, STAI 
and Neuroticism, were highly correlated with each other and assess the same construct, 
STAI and Neuroticism were standardized and averaged to create a 'Trait Anxiety' 
variable.  AD Anxiety was kept separate and primary analyses were run on both anxiety 
measures to detect possible differences between trait anxiety and more specific anxiety 
about AD on willingness to screen for AD.  
4. Development of Willingness to Screen for AD Scale 
A Principal Components Factor Analysis was conducted on items from the 
Willingness to Screen for AD questionnaire. One factor was extracted since all of the 
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items were designed to measure the unitary construct of willingness to screen. Five of the 
eight total items loaded highly (>.50) on one factor, which accounted for 52.76% of the 
total variance (Table 4). Three items did not load highly on the factor, and thus were 
excluded from primary analyses.  The AD item on the Willingness to Screen for Chronic 
Diseases questionnaire was highly correlated with the Willingness to Screen for AD scale 
(r = 0.70, p < .01). Due to this significant correlation, further analyses were performed 
using the Willingness to Screen for AD scale only.  
5. Correlations among Main Outcome Measures 
Correlations were run among the main study measures (Table 5). AD Anxiety and 
Willingness to Screen were significantly related to each other. AD Knowledge and AD 
Anxiety were not significantly correlated with each other, and AD Knowledge and Trait 
Anxiety were not significantly correlated with each other. As discussed above, AD 
Anxiety and Trait Anxiety were significantly correlated with each other, but were kept 
separate in primary analyses. Descriptive statistics for AD Knowledge, Willingness to 
Screen for AD, Trait Anxiety, and AD Anxiety are presented in Table 6.  
6. Demographic Differences 
a. Experience with AD 
The variable ‘Experience with AD’ was created based on four demographic items: 
(1) whether the participant had a family history of AD in their family, (2) whether they 
currently had a family member with AD, (3) whether they had any friends with AD, or (4) 
whether they had ever been a caregiver for someone with AD.  If the participant answered 
‘yes’ to any of the above items, they were included in the ‘Experience with AD’ variable, 
so that this variable reflected any participant that had had some type of experience with 
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persons with AD. Half of the participants had no experience with AD (n = 45), and half 
had experience with AD (n = 45). Six participants were not considered for the 
'Experience with AD' variable due to missing data.  An independent means t-test revealed 
no significant (p < .05) differences between participants with and without experience 
with AD on Trait Anxiety, AD Knowledge, Willingness to Screen for AD, or AD Anxiety 
(Table 7).   
b. Order of Measures  
Some participants completed the AD Knowledge quiz before filling out the AD 
Anxiety questionnaire (Order 1, n = 61) while other participants filled out the AD 
Anxiety questionnaire before completing the AD Knowledge quiz (Order 2, n = 35). An 
independent means t-test revealed no significant (p < .05) differences between 
participants in the Order 1 group versus those in the Order 2 group on Trait Anxiety, AD 
Knowledge, Willingness to Screen for AD, or AD Anxiety (Table 8).  
c. Paper versus Online Data Collection  
The majority of participants filled out the survey electronically through a survey 
website (n = 93), while a small amount filled out the paper version of the survey in 
person (n = 3), thus no analyses were performed to compare potential differences 
between the different formats of data collection.  
B. Primary Analyses 
 Primary analyses were multiple regressions to test the relationships between AD 
Knowledge, Trait Anxiety, AD Anxiety, and Willingness to Screen for AD. To test the 
first hypothesis (i.e., that greater knowledge would predict greater willingness to screen), 
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a regression analysis was run on the association between AD Knowledge and Willingness 
to Screen.  
Willingness = a + b1(AD Knowledge) + Error 
 AD Knowledge alone was not a significant predictor of Willingness to Screen for 
AD (B = 0.78, p > .05). The hypothesis that greater knowledge would predict greater 
willingness to screen was not supported. 
 To test the second hypothesis (i.e., that more anxiety would predict less 
willingness to screen), a regression analysis was run on the association between AD 
Anxiety and Willingness to Screen.  
Willingness = a + b1 (Anxiety) + Error 
 AD Anxiety was a significant predictor of Willingness to Screen for AD (B = 
0.25, p < .05).  More AD anxiety was associated with more willingness to screen for AD. 
In contrast, a regression analysis on the association between Trait Anxiety and 
Willingness to Screen indicated that Trait Anxiety was not a significant predictor of 
Willingness to Screen for AD (B = -0.06, p > .05). Thus, the second hypothesis that more 
anxiety would predict less willingness to screen was partially supported. While trait 
anxiety was not significantly associated with willingness to screen, AD anxiety in 
particular was significantly related to willingness to screen and it was associated with 
more willingness to screen.  
 The third and most novel hypothesis was that anxiety would moderate the 
relationship between AD Knowledge and Willingness to Screen. A moderated multiple 
regression determined how AD Knowledge, AD Anxiety, and the interaction between AD 
Knowledge and AD Anxiety predicted Willingness to Screen; these factors were entered 
in a blocked manner, one after the other (Table 9). AD Knowledge was not significantly 
32 
  
associated with Willingness to Screen. AD Anxiety was significantly associated with 
Willingness to Screen, after controlling for AD Knowledge. The interaction between AD 
Knowledge and AD Anxiety was of primary interest and this factor was a significant 
predictor of Willingness to Screen, after controlling for AD Knowledge and AD Anxiety.  
C. Post-hoc Analyses 
To interpret the significant interaction between AD Anxiety and AD Knowledge 
scores on Willingness to Screen for AD, a simple slopes analysis was performed 
following Aiken and West (1991). Amount of AD Knowledge was regressed separately 
on Willingness to Screen for AD for lesser (one standard deviation below the mean), and 
greater (one standard deviation above the mean) amounts of AD Anxiety as measured by 
total scores on the AD Anxiety scale.  
Individuals with greater anxiety about AD showed a significant negative 
relationship between AD Knowledge scores and Willingness to Screen for AD, B = -0.73, 
p < .01. In contrast, individuals with lesser anxiety about AD showed a significant 
positive relationship between AD knowledge and willingness to screen for AD, B = 2.40, 
p < .01. This interaction is illustrated in Figure 1.  
A moderated multiple regression was performed using Trait Anxiety as the 
anxiety measure. These variables were entered in a blocked manner, one after the other 
(Table 10).  AD Knowledge was not significantly associated with Willingness to Screen. 
Trait Anxiety was not significantly associated with Willingness to Screen, after 
controlling for AD Knowledge. The interaction between AD Knowledge and Trait 
Anxiety was not a significant predictor of Willingness to Screen, after controlling for AD 
Knowledge and Trait Anxiety.  
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CHAPTER VII 
DISCUSSION 
A. Summary of Current Study Results 
The current study determined how anxiety about AD moderates the association 
between knowledge about AD and willingness to screen for AD. Results indicated that 
knowledge has differential effects on willingness to screen based on levels of anxiety. 
When individuals had less AD anxiety than average, their willingness to screen increased 
as their amount of AD knowledge increased. In contrast, for participants with relatively 
more anxiety about AD, their willingness to screen decreased as their amount of AD 
knowledge increased.  
B. Interaction between AD Knowledge and AD Anxiety 
A focus of AD research is to increase general awareness and knowledge about 
AD to raise screening and early detection rates (e.g. Boustani et al., 2003; Devlin et al., 
2007), but older adults have anxiety about AD  (Boustani et al., 2003; Corner & Bond, 
2004; Devlin et al., 2007) that may impact how knowledge effects willingness to screen.  
Knowledge about AD is multifaceted and includes information about treatment options, 
course, and severity of the disease (Ayalon & Arean, 2004). Even though early detection 
of AD is shown to be beneficial for patients and caregivers and can lead to effective 
active management of the disease (Connell et al., 2009), current drug treatments have 
limited efficacy at treating the symptoms of AD and  cannot reverse the effects of the 
disease.  Older adults who know about this information may be inclined to alleviate their 
anxiety about AD by avoiding screening for the disease. That is, perhaps individuals with 
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greater AD knowledge suspect that a diagnosis of AD would not benefit them in any way, 
and are thus less willing to screen. Adult children of parents with AD may represent this 
group.  Even though adult children have knowledge about AD through their experience 
with the disease, they express an avoidance of the disease and report that they would 
delay getting a memory evaluation, even if they were experiencing memory problems 
(Corner & Bond, 2004). After witnessing AD in a parent, perhaps these adult children 
have both greater knowledge and greater anxiety about the disease and do not want to 
know if they have it themselves.  Future studies should continue to explore the interplay 
between knowledge and anxiety in family members of persons with AD and their 
healthcare decisions. A possible study could involve measuring knowledge, anxiety, and 
willingness to screen in a sample comprised of an equal amount of participants who have 
a family member with AD and participants with no family experience with the disease, in 
order to compare how knowledge and anxiety about AD effects each of these groups of 
participants differently.  
 The current study indicates that if information is presented to increase knowledge 
about AD, then perhaps there should be corresponding information aimed at reducing 
anxiety and fear about the disease. Devlin et al. (2007) suggest that providing adults with 
information about treatment options and education and counseling about AD could 
encourage people to seek an AD diagnosis.  For older adults who have less knowledge 
about AD, a different type of campaign should be designed. The theory of “fear appeals” 
proposes that a certain amount of fear can be utilized to raise anxiety and motivate people 
to engage in healthy behavior (Tanner et al., 1991). Results indicate that a campaign 
utilizing fear appeals to increase anxiety about AD should not also focus on increasing 
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knowledge about the disease, as that may mitigate the effectiveness of the fear appeal. A 
campaign designed to increase disease anxiety so that it becomes a motivator may be 
most effective only when targeting a group of individuals who do not have prior 
experience with and knowledge about AD. Overall, for each individual, there may be 
ideal levels of anxiety and knowledge that can be used together to produce the most 
effective AD awareness campaigns that will motivate individuals to seek treatment.  
C. Main Effect Finding of AD Anxiety 
Along with a moderation effect of anxiety on the relationship between AD 
knowledge and willingness to screen, there was also a main effect finding that AD 
anxiety was significantly associated with willingness to screen for AD, though in the 
opposite direction than expected. Without taking AD knowledge into account, 
participants who had more anxiety about AD were more willing to screen for the disease. 
This result was unexpected given previous findings. For example, Corner and Bond 
(2004) found that older adults’ fear and anxiety about AD influenced many of them to 
avoid thinking about the possibility of having AD. Similarly, older adults reported that 
they would avoid having a memory evaluation because of their fears about the disease 
(Devlin et al., 2007). Based on these compelling studies, it was expected that participants 
with more AD anxiety would be less willing to screen for AD. One possible explanation 
for the unexpected direction of the relationship between anxiety and willingness to screen 
could be that the participants in the study conducted by Corner and Bond (2004) had a 
mean age of 82, while the current study sample was made up of generally younger older 
adults, with a mean age of 62. Corner and Bond (2004) speculate that avoidance of 
talking or thinking about AD may increase with age. Perhaps our sample of younger older 
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persons represents individuals who are affected by disease anxiety differently than an 
older age group of older persons.  
It may be that for some individuals, anxiety may be motivating, rather than 
contributing to disease avoidance. Individuals who have anxiety about AD may become 
hypervigilant about checking for symptoms of the disease (Hodgson & Cutler, 2003; 
Cutler & Hodgson, 1996), and may be more willing to undergo evaluation and screening 
for AD. Cutler and Hodgson (1996) have conducted extensive research on the concept of 
“anticipatory dementia,” in which older adults have anxiety about memory changes and 
about developing AD in their lifetime. For these individuals, having some anxiety and 
fear about AD influences them to have memory symptoms checked and to seek screening 
for AD. Hodgson and Cutler (2003) propose that individuals with a higher level of 
education are more likely to have read or heard about AD and its symptoms, and 
therefore may be more likely to symptom seek for the disease in themselves. Hodgson 
and Cutler (2003) also found that holding higher-prestige occupations was related to 
more concern about developing AD in the future, suggesting that the thought of AD is 
more threatening to adults who hold cognitively-oriented jobs. The current study sample 
was highly educated and had an above average mean income. It is possible that they 
represented a group of adults who are more likely to be hyper-vigilant if they have 
anxiety about AD, and therefore express more willingness to screen.  
D. Exploring the Role of AD Knowledge 
Prior studies found that greater knowledge about AD was related to more 
willingness to screen for the disease (Galvin et al., 2007; Werner, 2003b; Ayalon & 
Arean, 2004: Werner, 2004). In the current study, there was no main effect for AD 
37 
  
knowledge; it was not significantly associated with willingness to screen for AD.  Galvin 
et al. (2007) found that older adults with more knowledge about AD had a higher 
perceived susceptibility of developing the disease, as well as a higher perceived benefit to 
treatment. They report that it was increases in these types of information that contributed 
to a higher intention to screen. Coupled with the current study's findings, perhaps it is not 
simply knowledge about AD that is related to willingness to screen, but the effect that AD 
knowledge has on older adults' perceived vulnerability and benefits of early detection of 
AD.  Edwards et al. (2000) found that while most respondents in their study knew that 
there was no cure for AD, they had significant misconceptions about available services 
for the disease. The authors speculate that having knowledge about services and treatment 
options increases personal awareness of the disease and enables service and treatment 
use. Future studies should further explore the roles that various types of knowledge about 
AD play in older adults' thinking about the effects of the disease. Perhaps simply 
knowing facts about AD is less important than knowing specific key aspects of the 
disease, such as treatment options. 
To our knowledge, no previous studies have used the ADKS as the primary 
measure of knowledge about AD when measuring the relationship between knowledge 
and willingness to screen for AD.  Since the ADKS was developed as a general measure 
of AD knowledge (Carpenter, 2009), as opposed to a measure of multiple components of 
knowledge about AD, it may not have captured the differential effects of specific AD 
knowledge on willingness to screen.  Future studies should explore the use of a range of 
knowledge measures with more specific content, to determine whether the knowledge 
measured by some is more related to willingness to screen than in others.  
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E. Limitations 
Our sample was comprised of mostly Caucasian, highly educated, and middle-
class older adults. Additionally, the majority of data were collected through an online 
survey site, which requires access to the internet and adequate computer skills. Thus, our 
sample may represent a specific cohort of older adults who fit those criteria. It is difficult 
to generalize these findings to the general population. Lack of representativeness is a 
limitation. 
Because of a lack of previous research on anxiety about AD, an AD anxiety 
questionnaire was created for this study. Additionally, a questionnaire to measure 
willingness to screen for AD was also created for this study. These are limitations since 
we could not be sure of these scales' reliability or validity in other samples. We hope our 
AD anxiety and willingness measures will continue to be developed and refined in future 
research. 
F. Conclusion and Future Research 
 While previous studies have identified that older adults have fear about AD 
(Corner & Bond, 2004; Devlin et al., 2007), the current study provided a specific 
assessment of AD anxiety. AD anxiety was a significant predictor of willingness to screen 
for AD. In addition, this anxiety moderated the effect of knowledge about AD on 
willingness to screen for AD. Thus, AD anxiety is an important construct to understand 
when developing effective health campaigns and screening programs for AD.  
 Future studies should further develop and refine the AD Anxiety questionnaire to 
facilitate exploration of this construct. AD anxiety represents a specific type of anxiety 
that had a different effect than trait anxiety on adults’ screening behavior. More studies 
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including measures of anxiety about AD, trait, and state anxiety may reveal more 
interesting insight into what influences decisions to screen or not for AD. Given that 
adults with more knowledge about AD may be less willing to screen for the disease when 
they have more anxiety about it, future studies should further examine the effect of 
knowledge on willingness to screen. It is possible that different aspects of knowledge 
about AD, such as symptoms, treatment, or personal experience affect older adults’ 
thoughts and feelings about the disease in different ways. By determining the specific 
effects of both knowledge and anxiety about AD, we can understand how these factors 
influence older adult's willingness to screen for the disease so that effective healthcare 
interventions can be implemented. 
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Table 1: Demographic Characteristics of Participants (N = 96) 
Characteristic    n  % 
Gender 
 Male    17  17.7 
 Female   79  82.3 
Race 
 White    94  97.9 
 American Indian,   1  1 
Alaska Native 
  
Education 
 High School Graduate/ 3  3.1 
GED 
Partial College  20  20.8 
College Graduate  23  24 
Master’s Degree  32  33.3 
Doctoral Degree, MD,  18  18.8 
or equivalent 
Income (Dollars) 
 0-15,000   5  5.2 
 15,000-30,000   14  14.6 
 30-000-45,000  17  17.7 
 45,000-60,000   19  19.8 
 60,000-75,000   7  7.3 
Above 75,000   31  32.4
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Table 2: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for 
AD, and AD Anxiety Between Genders 
 
Males  
      
Variable  n  M  SD  t  df 
 
1. Trait Anxiety 16  21.16  7.24  -0.57  90 
  
2. AD Knowledge 16  24.38  3.40  1.17  85 
 
3. Willingness  16  30.06  4.77  0.85  90 
   
4. AD Anxiety 16  15.50  4.18  1.30  87 
  
 
 
Females 
 
 
1.Trait Anxiety 76  22.17  6.36  -0.57  90 
 
2. AD Knowledge 71  23.49  2.56  1.17  85 
 
3.Willingness  76  28.71  5.95  0.85  90 
 
4. AD Anxiety 73  13.83  4.75  1.30  87 
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Table 3: Factor Loadings From Principal Components Analysis: Communalities, 
Eigenvalues, and Percentages of Variance for Items of the AD Anxiety Questionnaire 
(continued on to next page) 
 
          Factor Loading   
Item       1      Communality 
 
1. The older I become the more I worry   .78   .69 
about developing AD 
 
2. The thought of AD makes me anxious  .71   .66 
 
3. I avoid thinking about AD because it   .65   .52 
worries me 
 
4. I find it hard to stop worrying about AD  .60   .73 
 
5. I'm afraid that my life would have no   .60   .71 
meaning if I had AD 
 
6. I worry that if I developed AD I would feel .56   .45 
embarrassed and foolish 
 
7. I worry when I experience small memory   .55   .69 
slip-ups 
 
8. I am uncomfortable around individuals with  .45   .79 
AD 
 
9. I feel myself get anxious when I am around .42   .83 
individuals with AD 
 
10. Developing AD would ruin my life  .41   .59 
 
11. My heart races when I think about forgetting .37   .72 
who are my friends and family 
 
12. AD is something that people my age should be .34   .47 
concerned about 
 
13. I have trouble breathing when I think about AD .33   .61 
 
14. I expect that I would still feel the same about -.18   .76 
myself as I do now if I had AD. 
 
15. I would be able to adapt well if I developed AD -.16   .79 
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Eigenvalue       4.47 
         
% of variance        29.82 
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Table 4: Factor Loadings from Principal Component Factor Analysis: Communalities, 
Eigenvalues, and Percentage of Variance for Items of the Willingness to Screen for 
Alzheimer’s Disease Questionnaire 
 
        Factor Loading 
 
Item          1  
 Communality  
         
1. Rate how willing you would be to undergo   .80   .64 
a brief screening test for AD if you felt you were  
experiencing memory problems 
      
2. I would want to know as early as possible if   .89   .76  
I had AD 
 
3. If my primary care doctor was offering free   .87   .76 
screenings for AD, I would gladly do one 
 
4. Imagine a hypothetical situation in which you   .80   .64 
are suffering from signs of AD, rate how much  
you agree with this statement: I would seek  
professional help 
 
5. If my doctor told me I was experiencing signs  .85   .72 
of AD, I would want to get them evaluated as  
soon as possible 
 
6.If I noticed a friend not being able to complete  .31   .09 
daily tasks, I would urge them to talk to their  
doctors about these memory and functional changes 
 
7. I would like my doctor to give me a screening  .50   .25 
test for AD at every check up 
 
8. Please rate how likely you think it is that you will  -.07   .01 
develop AD at some point in the future.  
 
Eigenvalue       4.22 
% of variance       52.76 
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Table 5: Correlations among Trait Anxiety, Willingness to Screen for AD, AD 
Knowledge, and AD Anxiety 
 
 
Variable Trait Anxiety  Willingness   AD Knowledge  
Willingness  -0.06       
AD Knowledge -0.18  0.14        
AD Anxiety  0.39*  0.22**    -.07    
Note.* p < .05, ** p < .01 
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Table 6: Descriptive Statistics of Main Study Variables 
             
Variable  n    M  SD       Minimum  Maximum   Cronbach’s  
          Alpha 
Trait Anxiety  92    21.99 6.49    12.50 37 0.88 
AD Knowledge 87    23.66 2.74    17.00 29 0.79 
AD Anxiety  89    16.98 5.13    7.00  30 0.82 
Willingness to  92    28.95 5.76    7.00  35 0.87 
Screen for AD
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Table 7: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for 
AD, and AD Anxiety Between Experience and No Experience with AD 
 
   No Experience with AD 
Variable  n  M  SD  t  df  
      
1. Trait Anxiety 42  22.23  5.88  0.35  84 
  
2. AD Knowledge 39  23.87  2.75  0.21  80 
 
3. Willingness  41  30.00  4.22  1.75  84 
  
 
4. AD Anxiety 41  12.86  4.41  -1.91  82 
  
 
 
   Experience with AD 
 
   n  M  SD  t  df 
 
 
1.Trait Anxiety 44  21.73  7.18  0.35  84 
 
2. AD Knowledge 43  23.74  2.68  0.21  80 
 
3.Willingness  45  27.80  6.95  1.75  84 
 
4. AD Anxiety 43  15.07  4.78  -1.91  82 
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Table 8: Group Differences for Trait Anxiety, AD Knowledge, Willingness to Screen for 
AD, and AD Anxiety Between Orders 
    
Order 1    
Variable  n  M  SD  t  df  
      
1. Trait Anxiety 60  21.62  6.38  -0.76  90  
2. AD Knowledge 59  23.81  2.90  0.78  85 
 
3. Willingness  61  28.82  6.13  -0.29  90 
   
4. AD Anxiety 56  14.33  4.62  0.69  87 
  
 
 
Order 2 
 
   n  M  SD  t  df 
 
 
1.Trait Anxiety 32  22.70  6.74  -0.76  90 
 
2. AD Knowledge 28  23.32  2.37  0.78  85 
 
3.Willingness  31  29.19  5.04  -0.29  90 
 
4. AD Anxiety 33  13.74  4.83  0.69  87 
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Table 9: Willingness to Screen Moderated Regression: Predicting Willingness to Screen 
from AD Knowledge and AD Anxiety 
 
 
Dependent Variable  Independent Variables B SE  Beta    t 
 
Block 1   AD Knowledge  0.32 0.21 0.17 1.52  
    R2 = 0.03, F(1, 80) = 2.30 
 
Block 2   AD Knowledge  0.35 0.21 .018 1.68 
    AD Anxiety   0.24 0.12 0.22 2.03* 
    ∆R2 = 0.07, F(2, 79) = 3.27* 
 
Block 3   AD Knowledge  0.31 0.20 0.16 1.53 
    AD Anxiety   0.24 0.11 0.22 2.14* 
    Knowledge*Anxiety  -1.57 0.57 -0.29   -2.73** 
    ∆R2 = 0.16, F(3, 78) = 4.84** 
* p < .05, ** p < .01 
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Table 10: Willingness to Screen Moderated Regression: Predicting Willingness to Screen 
from AD Knowledge and Trait Anxiety 
________________________________________________________________________ 
 
Dependent Variable Independent Variables B  SE  Beta     t 
 
Block 1  AD Knowledge  0.78  0.60 0.14  1.30  
   R2 = 0.02, F(1, 84) = 1.70 
 
Block 2  AD Knowledge  0.77  0.61 0.14  1.25 
   Trait Anxiety   -0.07  0.62 -0.01  -0.11 
   ∆R2 = 0.00, F(2, 83) = 0.84 
 
Block 3  AD Knowledge  0.73  0.62 0.13  1.18 
   Trait Anxiety   -0.08  0.62 -0.01  -0.13 
   Knowledge*Anxiety  0.63  0.73 0.09  0.86 
   ∆R2 = 0.01, F(3, 82) = 0.81 
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Figure 1: Moderated Regression: Predicting Willingness to Screen from AD Knowledge 
and AD Anxiety 
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APPENDIX A 
 
BRIEF SCREENING QUESTIONNAIRE 
 
Please answer each of the following questions. 
 
1. Do you currently have a diagnosis of Mild Cognitive Impairment?   
 
   Yes      No 
 
 
 
2. Do you currently have a diagnosis of Alzheimer’s disease, or any other type of 
dementia? 
   
   Yes     No 
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APPENDIX B 
DEMOGRAPHIC QUESTIONNAIRE 
1. What is your age? 
 
 2. What is your gender? 
0) M     
1) F 
 
 3. Are you retired or employed? 
 0) Retired 
 1) Employed 
  If employed, do you work full time or part time? 
  0) Full time 
 1) Part time 
 
 4. Please circle which of the following best describes your current income: 
 0)  0-15,000  
 1) 15,000-30,000   
 2) 30,000-45,000   
 3)  45,000-60,000   
 4) 60,000-75,000 
 5)  Above 75,000 
 5. What is the highest level of education you have completed? (Please circle one) 
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 0) Less than 7 years of school (6th grade or less)  
 1) Junior High School (completed grades 7, 8, or9)  
 2) Partial High School (completed grade 10 or 11)  
 3)  High School Graduate or GED  
 4) Partial college  
 5) College Graduate  
 6) Master's Degree 
 7) Doctoral Degree, or MD, or the equivalent 
 
 
 6. Are you Hispanic or Latino? 
 0) Yes        
 1) No        
 2) Don’t know/Not sure  
 
 7. Which one of these groups would you say best represents your race?   
 0) White  
 1) Black or African American  
 2) Asian  
 3) Native Hawaiian or Other Pacific Islander  
   4) American Indian, Alaska Native 
   5) Other (specify) 
   6) Don’t know/Not sure 
 
 
8. What is your marital status? (Please circle one) 
0) Married 
1) Widowed  
2) Divorced  
3) Separated 
 4) Never married 
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 5) A member of an unmarried couple 
 
 9. Is there a family history of Alzheimer’s disease in your family? 
 0) Yes             
 1) No 
 
 10. Does anyone in your family currently have Alzheimer’s disease? 
 0) Yes            
 1)  No 
  
 11. Do you have any friends with Alzheimer's disease? 
 0) Yes         
 1) No 
 
12. Have you ever been a caregiver for someone with Alzheimer’s disease?  
0) Yes 
1) No 
If yes, please describe the nature of your relationship: 
 
13. Do you have any concerns about your memory functioning at the present time? 
0) Yes 
1) No 
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14. How would you rate your overall health at the present item? 
0) Extremely poor 
1) Very poor  
2) Average  
3) Very Good  
4) Excellent 
 
15. Have you ever been diagnosed and/or treated with a psychiatric or mental disorder? 
0) Yes 
1) No 
 
16. Have you ever had a memory evaluation before? 
0) Yes 
1) No 
If yes, please describe where and when: 
 
17. Do you see your doctor for regular check-ups? 
0) Yes 
1) No 
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APPENDIX C 
WILLINGNESS TO SCREEN FOR CHRONIC DISEASES 
 
On a scale of 1-10, with 1 being not at all willing and 10 being completely willing, please 
rate how willing you would be to screen for the following diseases if you felt you were 
experiencing some initial signs of the disease: 
Cancer   
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Heart Disease 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Diabetes 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Parkinson's Disease 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Alzheimer's disease 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Arthritis 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Osteoporosis 
 
 1 2 3 4 5 6 7 8 9 10 
 
 58 
 
 
Hypertension 
 
 1 2 3 4 5 6 7 8 9 10 
 
 
Glaucoma 
 
 1 2 3 4 5 6 7 8 9 10 
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APPENDIX D 
KNOWLEDGE QUIZ 
Please read each statement carefully and decide whether you think it is true or false, by 
circling either “T” if you think the statement is all true or mostly true, and “F” if you 
think the statement is all false or mostly false. 
1. People with Alzheimer's disease are particularly prone to depression.     T     F 
2. It has been scientifically proven that mental exercise can prevent a person from 
getting Alzheimer's disease.     T     F 
3. After symptoms of Alzheimer's disease appear, the average life expectancy is 6 to 
12 years.     T     F 
4. When a person with Alzheimer's disease becomes agitated, a medical examination 
might reveal other health problems that caused the agitation.     T     F 
5. People with Alzheimer's disease do best with simple, instructions given one step 
at a time.     T     F 
6. When people with Alzheimer's disease begin to have difficulty taking care of 
themselves, caregivers should take over right away.     T     F 
7. If a person with Alzheimer's disease becomes alert and agitated at night, a good 
strategy is to try to make sure that the person gets plenty of physical activity during the 
day.  T    F      
8. In rare cases, people have recovered from Alzheimer's disease     T     F 
9. People whose Alzheimer's disease is not yet severe can benefit from 
psychotherapy for depression and anxiety.     T     F 
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10. If trouble with memory and confused thinking appears suddenly, it is likely due to 
Alzheimer's disease.     T     F 
11. Most people with Alzheimer's disease live in nursing homes.     T     F 
12. Poor nutrition can make the symptoms of Alzheimer's disease worse.     T     F 
13. People in their 30s can have Alzheimer's disease.     T     F 
14. A person with Alzheimer's disease becomes increasingly likely to fall down as the 
disease gets worse.     T     F 
15. When people with Alzheimer's disease repeat the same question or story several 
times, it is helpful to remind them that they are repeating themselves.     T     F 
16. Once people have Alzheimer's disease, they are no longer capable of making 
informed decisions about their own care.     T     F 
17. Eventually, a person with Alzheimer's disease will need 24-hour supervision.  
T     F 
18. Having high cholesterol may increase a person's risk of developing Alzheimer's 
disease. T     F 
19. Tremor or shaking of the hands or arms is a common symptoms in people with 
Alzheimer's disease.     T     F 
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer's 
disease. T     F 
21. Alzheimer's disease is one type of dementia.     T     F 
22. Trouble handling money or paying bills is a common early symptoms of 
Alzheimer's disease.     T     F 
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23. One symptom that can occur with Alzheimer's disease is believing that other 
people are stealing one's things.     T     F 
24. When a person has Alzheimer's disease, using reminder notes is a crutch that can 
contribute to decline.     T     F 
25. Prescription drugs that prevent Alzheimer's disease are available.     T     F 
26. Having high blood pressure may increase a person's risk of developing 
Alzheimer's disease.     T     F 
27. Genes can only partially account for the development of Alzheimer's disease. T   F 
28. It is safe for people with Alzheimer's disease to drive, as long as they have a 
companion in the car at all times.      T     F 
29. Alzheimer's disease cannot be cured.     T     F 
30. Most people with Alzheimer's disease remember recent events better than things 
that happened in the past.     T     F 
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APPENDIX E 
ANXIETY ABOUT AD QUESTIONNAIRE 
Please read each of the following statements carefully and rate how much you agree with 
each statement, ranging from “Strongly disagree” to “Strongly Agree”. 
1. I find it hard to stop worrying about AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
2. I worry when I experience small memory slip ups 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
3. I worry that if I developed AD, I would feel embarrassed and foolish 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
4. Developing AD would ruin my life 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
5. I am uncomfortable around individuals with AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
6. I would be able to adapt well if I developed AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
7. AD is something that people my age should be concerned about 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
8. I have trouble breathing when I think about AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
9. I feel myself get anxious when I am around individuals with AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
10. My heart races when I think about forgetting who are my friends and family 
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Strongly disagree Disagree Don't know Agree     Strongly Agree 
11. The older I become, the more I worry about developing AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
12. I'm afraid that my life would have no meaning if I had AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
13. I expect that I would still feel the same about myself as I do now if I had AD 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
14. The thought of AD makes me anxious 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
15.  I avoid thinking about AD because it worries me. 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
16. Please describe what comes to mind when you think about AD. 
17.  Please describe how you feel about the possibility of developing AD at some 
point in the  future. 
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 APPENDIX F 
STATE TRAIT ANXIETY SCALE 
Directions:A number of statements which people have used to describe themselves are 
given below. Read each statement and then circle the appropriate value to the right of the 
statement to indicate how you feel generally on a scale from one to four, with “1” 
indicating that you feel that way “Not at all,” “2” that you feel that way “Somewhat,” “3” 
that you feel that way “Moderately So” and “4” that you feel that way “Very much So.”  
There are no right or wrong answers.  Do not spend too much time on any one statement 
but give the answer which seems to describe your present feelings best.  
 
 1. I feel calm………………………………………. 1    2      3        4  
 
 2. I feel secure……………………………………  1    2            3        4 
 
 3. I am tense……………………………………… 1    2      3        4 
 
 4. I feel strained…………………………………… 1    2      3        4 
 
 5. I feel at ease……………………………………... 1    2      3        4 
 
 6. I feel upset…………………………………….... 1    2      3        4 
 
 7. I am presently worrying over possible misfortunes…1    2      3        4 
 
 8. I feel satisfied……………………………….… 1    2      3        4 
 
 9. I feel frightened…………………………………. 1    2      3        4 
 
 10. I feel comfortable………………………………. 1    2      3        4 
 
 11. I feel self-confident…………………………….. 1    2      3        4 
 
 12. I feel nervous………………………………… 1    2      3        4 
 
 13. I am jittery……………………………………… 1    2      3        4 
 
 14. I feel indecisive………………………………… 1    2      3        4 
 
 15. I am relaxed…………………………………… 1    2      3        4 
 
16. I feel content…………………………………… 1    2      3        4 
 
 17. I am worried……………………………...…….. 1    2      3        4 
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 18. I feel confused………………………………….. 1    2      3        4 
 
 19. I feel steady…………………………………….. 1    2      3        4  
 
 20. I feel pleasant……………………………...…… 1    2      3        4 
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APPENDIX G 
 
TEN-ITEM PERSONALITY INVENTORY   
  
Here are a number of personality traits that may or may not apply to you.  Please write a 
number next to  
each statement to indicate the extent to which you agree or disagree with that statement. 
You should rate the extent to which the pair of traits applies to you, even if one 
characteristic applies more strongly than the other.   
  
  
  
Disagree   Disagree    Disagree      Neither agree    Agree        Agree             Agree  
strongly   moderately    a little        nor disagree     a little        moderately      strongly  
  
1        2     3        4         5    6      7  
 
I see myself as:  
  
1.    _____  Extraverted, enthusiastic.  
  
2.    _____  Critical, quarrelsome.  
  
3.    _____  Dependable, self-disciplined.  
  
4.    _____  Anxious, easily upset.  
  
5.    _____  Open to new experiences, complex.  
  
6.    _____  Reserved, quiet.  
  
7.    _____  Sympathetic, warm.  
  
8.    _____  Disorganized, careless.  
  
9.    _____  Calm, emotionally stable.  
  
10._____  Conventional, uncreative. 
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APPENDIX H 
WILLINGNESS TO SCREEN FOR AD  
1. On a scale of 1-10, with 1 being not at all willing and 10 being completely 
willing, please rate how willing you would be to undergo a brief screening test for 
Alzheimer’s disease if you felt you were experiencing memory problems. 
 
1 2 3 4 5 6 7 8 9 10 
 
Please rate how much you agree with the following statements. 
      2.   I would want to know as early as possible if I had AD. 
 Strongly disagree Disagree Don't know Agree Strongly Agree  
 
3.  If my primary care doctor was offering free screenings for AD, I would gladly do 
one 
 Strongly disagree Disagree Don't know Agree    Strongly Agree  
 
4. For the following question, please imagine a hypothetical situation in which you 
were suffering from signs of AD, and then rate how much you agree with the 
following statement:  I would seek professional help (such as from my primary 
care doctor, family physician, psychiatrist, psychologist, neurologist, social 
worker). 
 Strongly disagree Disagree Don't know Agree     Strongly Agree  
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5. If I noticed a friend not being able to complete daily tasks and forgetting 
appointments and peoples’ names, I would urge them to talk to their doctors about 
these memory and functional changes. 
Strongly disagree   Disagree Don't know Agree     Strongly Agree  
 
6. If  my doctor told me I was experiencing signs of Alzheimer's disease, I would 
want to get them evaluated as soon as possible. 
Strongly disagree Disagree Don't know Agree     Strongly Agree  
 
7.  I would like my doctor to give me a screening test for Alzheimer's disease at 
every        check-up. 
Strongly disagree Disagree Don't know Agree     Strongly Agree 
 8.  On a scale of 1 to 10, with 1 being extremely unlikely, and 10 being extremely 
 likely,  please rate how likely you think it is that you will develop Alzheimer's 
 disease at some point in the future. 
  1  2  3 4 5 6 7 8 9 10 
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